Recovery. Metabolic health. Performance. Longevity. Cognitive function. Each research goal has specific compounds people are studying. Here's the plain-English breakdown — matched to what you're trying to understand.
The most actively researched category in the fitness and athletic community. These compounds are studied for their potential to accelerate tissue healing, reduce inflammation, and support recovery from injury. BPC-157 and TB-500 are the two most studied — and are almost always researched together.
BPC-157 works locally — targeting the specific site of injury or inflammation. TB-500 works systemically — mobilizing cells throughout the body toward sites of damage. Together they cover local and systemic recovery simultaneously. This combination has more published preclinical research than any other peptide pairing in the recovery category.
| Compound | What It's Studied For | Research Strength | Verified Source |
|---|---|---|---|
| BPC-157Body Protection Compound | Tendon repair, gut lining integrity, tissue healing, anti-inflammatory pathways. 15-amino acid sequence from gastric juice protein. | Hundreds of studiesPreclinical |
ReViaLife → |
| TB-500Thymosin Beta-4 Fragment | Cellular migration to injury sites, systemic tissue recovery, cardiac repair models, inflammation reduction. | Strong preclinicalSystemic |
ReViaLife → |
| Pentadeca ArginatePDA · BPC-157 Variant | Similar to BPC-157 with arginine modification. Emerging research suggests potentially enhanced bioavailability. Studied as BPC-157 alternative. | EmergingLimited data |
ReViaLife → |
| KPVTripeptide Anti-Inflammatory | Gut inflammation, wound healing, anti-inflammatory signaling. A tripeptide fragment of alpha-MSH with strong gut health research. | Growing literatureGut focused |
ReViaLife → |
The most searched peptide research category online. GLP-1 agonists became mainstream through Ozempic and Wegovy — but the research compounds predate the pharmaceutical products by years. These are studied for metabolic function, appetite regulation, and body composition.
| Compound | What It's Studied For | Research Strength | Verified Source |
|---|---|---|---|
| SemaglutideGLP-1 Receptor Agonist | Appetite regulation via GLP-1 receptor agonism, insulin sensitivity, body composition changes. Most published metabolic research compound. Same mechanism as Ozempic — different regulatory context. | Thousands of studiesVery strong |
ReViaLife → |
| TirzepatideGIP + GLP-1 Dual Agonist | Dual receptor targeting — GLP-1 and GIP simultaneously. Different metabolic profile than semaglutide alone. Research has shown notable body composition findings. Same molecule as Mounjaro/Zepbound. | Strong clinical dataDual mechanism |
ReViaLife → |
| RetatrutideGLP-1 + GIP + Glucagon Triple Agonist | Hits three receptors — adding glucagon to GLP-1 and GIP. Glucagon increases energy expenditure. Among the most closely watched emerging metabolic compounds. Still in research phase. | EmergingEarly clinical |
ReViaLife → |
| AOD-9604GH Fragment 177-191 | Fragment of growth hormone studied specifically for fat metabolism. Research has examined lipolysis (fat breakdown) pathways. Studied as a more targeted metabolic alternative to full GH peptides. | Moderate literatureFat focused |
ReViaLife → |
GH axis compounds are the most studied in the performance and fitness research community. Unlike synthetic HGH, these peptides work with your body's existing growth hormone release system — prompting your own pituitary to produce and release GH more effectively.
| Compound | What It's Studied For | Research Strength | Verified Source |
|---|---|---|---|
| CJC-1295 / IpamorelinGHRH + GHRP Stack | Always studied together. CJC-1295 primes the pituitary for GH release. Ipamorelin triggers the release. Combined effect on pulsatile GH secretion, body composition, sleep quality, and recovery. | Most studied GH stackStrong preclinical |
ReViaLife → |
| MK-677 (Ibutamoren)Oral GH Secretagogue | Oral GH secretagogue — stimulates GH and IGF-1 release. Studied for lean mass, sleep quality, and recovery. Unlike most peptides, studied in oral form. Technically not a peptide but closely associated. | Clinical data existsOral |
ReViaLife → |
| GHRP-6 / GHRP-2Growth Hormone Releasing Peptides | Earlier generation GHRPs. Still studied for GH secretion, appetite stimulation (GHRP-6), and body composition. Ipamorelin has largely replaced these due to cleaner GH release profile. | Established researchOlder compounds |
ReViaLife → |
| Follistatin 344Myostatin Inhibitor | Studies have examined its role in inhibiting myostatin — the protein that limits muscle growth. Research in animal models has shown significant lean mass changes. Limited human data. | Animal modelsLimited human |
ReViaLife → |
The fastest-growing research category — driven by the intersection of longevity science, cosmetic research, and biohacking. These compounds are studied for their effects on aging biology, collagen synthesis, skin remodeling, and in some cases telomere biology.
| Compound | What It's Studied For | Research Strength | Verified Source |
|---|---|---|---|
| GHK-CuCopper Peptide Tripeptide | Collagen and elastin synthesis, wound healing, skin remodeling, anti-inflammatory activity. Naturally occurring — levels decline dramatically with age. Used in high-end cosmetics; research-grade differs significantly. | Extensive publishedStrong cosmetic data |
ReViaLife → |
| EpithalonTelomere Research Peptide | Telomere preservation and lengthening via telomerase activation. Lifespan extension in animal models. Immune function. Antioxidant activity. Developed in Russia from pineal gland research. | Strong animal dataRussian literature |
ReViaLife → |
| Thymosin Alpha-1Immune Modulator | Immune system modulation, thymic function, antiviral and antibacterial activity. Has been approved as a pharmaceutical in some countries for specific immune conditions. | Clinical dataApproved in some regions |
ReViaLife → |
| Snap-8 / ArgirelineCosmetic Peptides | Topical application research — studied for wrinkle reduction through muscle contraction inhibition. Often called "Botox alternative" in cosmetic research — mechanism is different but studied for similar aesthetic outcomes. | Cosmetic focusedTopical |
ReViaLife → |
Nootropic peptides are studied for their effects on anxiety, cognitive performance, memory, and neuroprotection. Several originated from Soviet/Russian research programs and have limited Western clinical data — but an emerging body of preclinical and observational research.
| Compound | What It's Studied For | Research Strength | Verified Source |
|---|---|---|---|
| SelankTuftsin Analog · Anxiolytic | Anxiety reduction, cognitive enhancement, BDNF upregulation, anti-stress effects. Russian-developed tuftsin analog. Some clinical studies conducted in Russia. Nasal administration typically studied. | Russian clinicalAnxiety focused |
ReViaLife → |
| SemaxACTH Derivative · Nootropic | Cognitive performance, memory enhancement, neuroprotection, BDNF promotion. ACTH 4-10 analog developed in Russia. Studied for stroke recovery and cognitive decline in Russian literature. | Russian clinicalNeuroprotective |
ReViaLife → |
| DihexaAngiotensin IV Analog | Cognitive enhancement, memory formation, synaptogenesis. Studies have shown potent cognitive effects in animal models — estimated to be significantly more potent than BDNF for synapse formation in preclinical research. | Potent animal dataLimited human |
ReViaLife → |
Certain compounds are almost always studied together because their proposed mechanisms are complementary. Here are the most researched combinations and why they're paired.
Local + systemic coverage. BPC-157 targets the injury site directly. TB-500 mobilizes cells throughout the body. Together they cover repair from both directions. The most studied recovery combination in preclinical literature.
Signal + trigger. CJC-1295 (GHRH analog) tells the pituitary to get ready. Ipamorelin (GHRP) pulls the trigger on GH release. Together they produce a stronger, more natural GH pulse than either alone. Almost always studied as a pair.
Cellular repair + longevity signaling. GHK-Cu stimulates collagen and activates repair genes. Epithalon targets telomere preservation. Studied together in longevity research protocols for complementary anti-aging mechanisms.
Appetite regulation + fat metabolism. GLP-1 compounds manage appetite and insulin signaling. AOD-9604 targets lipolysis pathways directly. Some researchers study these together for more comprehensive metabolic coverage.
Every compound above is available at ReViaLife with a published third-party CoA. Get the free supplier checklist and library access with your email.
For adults 21+. Research use only. No spam. Unsubscribe anytime.